Orchestra BioMed Holdings (OBIO) Long-Term Investments (2020 - 2025)

Orchestra BioMed Holdings (OBIO) has 6 years of Long-Term Investments data on file, last reported at $2.5 million in Q4 2025.

• On a quarterly basis, Long-Term Investments changed 0.2% year-over-year to $2.5 million in Q4 2025; TTM through Dec 2025 was $2.5 million, a 0.2% change from a year earlier, with the FY2025 full-year figure at $2.5 million, changed 0.2% from the prior year.
• Long-Term Investments for Q4 2025 stood at $2.5 million, roughly flat from $2.5 million in the prior quarter.
• Over the last five years, Long-Term Investments for OBIO reached as high as $160.2 million in Q2 2022 and fell as low as $2.5 million in Q4 2022.
• Historically, Long-Term Investments has averaged $53.0 million across 5 years, with a median of $2.5 million in 2024.
• Across the five-year window, Long-Term Investments sank 98.44% in 2023 and grew 0.2% in 2024, its largest moves.
• Year by year, Long-Term Investments stood at $160.0 million in 2021, then tumbled by 98.44% to $2.5 million in 2022, then changed by 0.0% to $2.5 million in 2023, then changed by 0.0% to $2.5 million in 2024, then climbed by 0.2% to $2.5 million in 2025.
• Per Business Quant data, the three most recent Long-Term Investments figures were $2.5 million in Q4 2025, $2.5 million in Q3 2025, and $2.5 million in Q2 2025.